Synopsis
Synopsis
0
CEP/COS
0
VMF
0
FDA Orange Book
0
Canada
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. (2s)-(((3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile
2. Galvus
3. Nvp Laf237
4. Nvp-laf237
5. Vildagliptin
1. Vildagliptin
2. 274901-16-5
3. (2r)-1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile
4. Vildagliptin (2r)-isomer
5. Schembl671629
6. Dtxsid301119534
7. Akos015969326
8. F78360
9. A819091
10. (2r)-1-[2-[(3-hydroxy-1-adamantyl)amino]-1-oxoethyl]-2-pyrrolidinecarbonitrile
11. (2r)-1-[2-[(3-oxidanyl-1-adamantyl)amino]ethanoyl]pyrrolidine-2-carbonitrile
12. (2r)-1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidine Carbonitrile; (r)-1-(2-(((1r,3s,5r,7s)-3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile
13. Rel-(2r)-1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile
1. Jalra
2. Equa
| Molecular Weight | 303.4 g/mol |
|---|---|
| Molecular Formula | C17H25N3O2 |
| XLogP3 | 0.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 303.19467705 g/mol |
| Monoisotopic Mass | 303.19467705 g/mol |
| Topological Polar Surface Area | 76.4 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 523 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:
as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control
Vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:
- as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance.
- in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 and 5. 1 for available data on different combinations).
Vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:
- as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance.
- in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 and 5. 1 for available data on different combinations).
Treatment of type II diabetes mellitus
Dipeptidyl-Peptidase IV Inhibitors
Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release. (See all compounds classified as Dipeptidyl-Peptidase IV Inhibitors.)
Hypoglycemic Agents
Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)
A10BH02
A10BH02
A10BH02
A - Alimentary tract and metabolism
A10 - Drugs used in diabetes
A10B - Blood glucose lowering drugs, excl. insulins
A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors
A10BH02 - Vildagliptin
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36545
Submission : 2022-01-03
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28133
Submission : 2014-04-17
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33178
Submission : 2018-09-13
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29933
Submission : 2015-10-14
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34972
Submission : 2020-06-30
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31663
Submission : 2017-04-05
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32645
Submission : 2018-03-30
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27040
Submission : 2013-05-16
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26461
Submission : 2012-09-20
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35397
Submission : 2021-05-21
Status : Active
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Century has been an API manufacturer for over 40 years & is the partner of choice for multipurpose custom manufacturing projects.
Date of Issue : 2025-10-07
Valid Till : 2028-10-06
Written Confirmation Number : WC-0293
Address of the Firm : 103-106, GIDC Halol, Dist.-Panchmahal, Pin-389350, Gujarat, India
Date of Issue : 2025-08-05
Valid Till : 2028-06-25
Written Confirmation Number : WC-0054
Address of the Firm : Block No. 82/B, ECP Road, At & Post Karakhadi, Tal - Padra, Dist. Baroda, Gujara...
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
Date of Issue : 2025-09-03
Valid Till : 2028-09-02
Written Confirmation Number : WC-0362
Address of the Firm : Plot No:4, Hetero Infrastructure SEZ Ltd.,Narasapuram, Visakhapatnam-531081, And...
Date of Issue : 2025-08-22
Valid Till : 2028-08-21
Written Confirmation Number : WC-0082
Address of the Firm : Karakhadi, Plot No. 842-843, At - Karakhdi, Tal. - Padra, Dist -Vadodara, Gujara...

Date of Issue : 2022-07-06
Valid Till : 2025-06-25
Written Confirmation Number : WC-0057n
Address of the Firm : Plot No. 3109, GIDC, Industrial Estate Ankleshwar, Distt- Bharuch - 393002, Guja...

Date of Issue : 2025-08-19
Valid Till : 2028-07-02
Written Confirmation Number : WC-0100
Address of the Firm : Special Economic Zone, Plot No. 2, 3, 4 & 5, Phase IV, Bommasandra-Jigani Link R...

Date of Issue : 2025-10-16
Valid Till : 2028-07-21
Written Confirmation Number : WC-0044
Address of the Firm : Plot No. A-100, A-100/1, A-100/2 & D-1, M.I.D.C Ind. Area, Shendra, Aurangabad-4...

Date of Issue : 2022-06-14
Valid Till : 2025-07-02
Written Confirmation Number : WC-0094nA2A
Address of the Firm : Plot No. 72 & 82/A, KIADB Industrial Area, Jigani, Anekal Taluk, Bengaluru-560 1...

Date of Issue : 2025-10-01
Valid Till : 2028-07-02
Written Confirmation Number : WC-0087
Address of the Firm : Plot No.1 to 5, 31 to 35 & 48 to 51, 26 & Kl201, Village Lakhmapur, Taluka Dindo...

Date of Issue : 2025-09-08
Valid Till : 2028-08-15
Written Confirmation Number : WC-0022
Address of the Firm : Plot No. 182 to 186, 192-A and 193 to 197 & 212/A,B,C,D Phase-ll, IDA, Pashamyla...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Century has been an API manufacturer for over 40 years & is the partner of choice for multipurpose custom manufacturing projects.
Registrant Name : Hokem Trading Co., Ltd.
Registration Date : 2025-01-14
Registration Number : Su6192-1-ND
Manufacturer Name : Century Pharmaceuticals Limi...
Manufacturer Address : 103 To 106, GIDC, Halol City. - Holol – 389 350 Dist. - Panchmahal, Gujarat State, ...
Registrant Name : Sam-O Pharmaceutical Co., Ltd.
Registration Date : 2020-07-07
Registration Number : Su207-43-ND
Manufacturer Name : Moehs BCN, SL
Manufacturer Address : Polígono Industrial Aquiberia, c/Zenc, 12 08755 Castellbisbal (Barcelona) Spain
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2021-06-22
Registration Number : Su434-39-ND
Manufacturer Name : Ami Lifesciences Pvt. Ltd.
Manufacturer Address : Block No. 82/B, ECP Road, At & Post. Karakhadi-391 450, Taluka:Padra, Dist.Vadodara, ...
Registrant Name : Coapharm Bio Co., Ltd.
Registration Date : 2024-02-05
Registration Number : Su152-1-ND
Manufacturer Name : Bajaj Healthcare Limited (Un...
Manufacturer Address : Block No. 588, Savli Karachia Road, At & Post - Gothada, Tal-Savli, Dist - Vadodara -...

Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2024-07-29
Registration Number : Su152-1-ND(1)
Manufacturer Name : Bajaj Healthcare Limited
Manufacturer Address : (Unit–II), Block No. 588, Savli- Karachia Road, At & Post: Gothada Tal: Savli, Dist...

Registrant Name : Novartis Korea
Registration Date : 2024-01-31
Registration Number : Su196-28-ND
Manufacturer Name : Harman Finochem Limited
Manufacturer Address : A-100, A-100/1, A-100/2 & D-1, MIDC Industrial Area, Shendra, Aurangabad -431 007, Ma...

Registrant Name : Otran Korea Co., Ltd.
Registration Date : 2022-08-30
Registration Number : Su695-11-ND
Manufacturer Name : Hunan Jiudian Hongyang Pharm...
Manufacturer Address : Tongguan Circular Economy Industrial base, Wangcheng Economic and Technological Devel...

Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2025-04-16
Registration Number : Number 946-4-ND(1)
Manufacturer Name : Jiangxi Synergy Pharmaceutic...
Manufacturer Address : Jiangxi Fengxin Industrial Park, Fengxin, 330700, Jiangxi Province, China

Registrant Name : Agerson Bio Co., Ltd.
Registration Date : 2024-07-16
Registration Number : Number 946-4-ND
Manufacturer Name : Jiangxi Synergy Pharmaceutic...
Manufacturer Address : Jiangxi Fengxin Industrial Park, Fengxin, 330700, Jiangxi Province, China

Registrant Name : Hokem Trading Co., Ltd.
Registration Date : 2025-12-30
Registration Number : Su6192-3-ND
Manufacturer Name : Zhejiang Guobang Pharmaceuti...
Manufacturer Address : No. 6, Weiwu Road, Hangzhou Gulf Shangyu Economic and Technological Development Zone,...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CAS Number : 702-82-9
End Use API : Vildagliptin
About The Company : Tagoor Laboratories, established in 2018 and part of the Tagoor Group, provides APIs, advanced intermediates, and key starting materials for critical and high-g...
(S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile
CAS Number : 207557-35-5
End Use API : Vildagliptin
About The Company : Tagoor Laboratories, established in 2018 and part of the Tagoor Group, provides APIs, advanced intermediates, and key starting materials for critical and high-g...
(2S)-1-(Chloroacetyl)-2-Pyrrolidinecarbonitrile
CAS Number : 207557-35-5
End Use API : Vildagliptin
About The Company : Suanfarma is a B2B life sciences company focused on developing, manufacturing, and distributing high-quality ingredients for the pharmaceutical industry in an i...
CAS Number : 702-82-9
End Use API : Vildagliptin
About The Company : Suanfarma is a B2B life sciences company focused on developing, manufacturing, and distributing high-quality ingredients for the pharmaceutical industry in an i...
CAS Number : 62937-45-5
End Use API : Vildagliptin
About The Company : PMC Isochem, acquired by PMC International in 2017, is a CDMO manufacturing cGMP intermediates, APIs, and functional excipients for global pharmaceutical and pe...
(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile
CAS Number : 207557-35-5
End Use API : Vildagliptin
About The Company : Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and sales centers in Zhejiang, Shandong, and Henan. With fa...
CAS Number : 702-82-9
End Use API : Vildagliptin
About The Company : Olpha, a subsidiary of JSC AB City, is one of the largest companies in the Baltic states with 50 years of experience in producing medicines and chemical pharmac...
CAS Number : 5001-18-3
End Use API : Vildagliptin
About The Company : Olpha, a subsidiary of JSC AB City, is one of the largest companies in the Baltic states with 50 years of experience in producing medicines and chemical pharmac...
CAS Number : 702-82-9
End Use API : Vildagliptin
About The Company : Oxygenta Pharmaceutical Limited was incorporated as a private limited company in 1990 and later converted into a limited company in 1993. The company was establ...
(S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile
CAS Number : 207557-35-5
End Use API : Vildagliptin
About The Company : Oxygenta Pharmaceutical Limited was incorporated as a private limited company in 1990 and later converted into a limited company in 1993. The company was establ...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
87
PharmaCompass offers a list of Vildagliptin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Vildagliptin manufacturer or Vildagliptin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vildagliptin manufacturer or Vildagliptin supplier.
A Vildagliptin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vildagliptin, including repackagers and relabelers. The FDA regulates Vildagliptin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vildagliptin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vildagliptin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Vildagliptin supplier is an individual or a company that provides Vildagliptin active pharmaceutical ingredient (API) or Vildagliptin finished formulations upon request. The Vildagliptin suppliers may include Vildagliptin API manufacturers, exporters, distributors and traders.
click here to find a list of Vildagliptin suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Vildagliptin DMF (Drug Master File) is a document detailing the whole manufacturing process of Vildagliptin active pharmaceutical ingredient (API) in detail. Different forms of Vildagliptin DMFs exist exist since differing nations have different regulations, such as Vildagliptin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vildagliptin DMF submitted to regulatory agencies in the US is known as a USDMF. Vildagliptin USDMF includes data on Vildagliptin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vildagliptin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vildagliptin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Vildagliptin Drug Master File in Japan (Vildagliptin JDMF) empowers Vildagliptin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Vildagliptin JDMF during the approval evaluation for pharmaceutical products. At the time of Vildagliptin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Vildagliptin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Vildagliptin Drug Master File in Korea (Vildagliptin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Vildagliptin. The MFDS reviews the Vildagliptin KDMF as part of the drug registration process and uses the information provided in the Vildagliptin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Vildagliptin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Vildagliptin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Vildagliptin suppliers with KDMF on PharmaCompass.
A Vildagliptin written confirmation (Vildagliptin WC) is an official document issued by a regulatory agency to a Vildagliptin manufacturer, verifying that the manufacturing facility of a Vildagliptin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Vildagliptin APIs or Vildagliptin finished pharmaceutical products to another nation, regulatory agencies frequently require a Vildagliptin WC (written confirmation) as part of the regulatory process.
click here to find a list of Vildagliptin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vildagliptin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vildagliptin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vildagliptin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vildagliptin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vildagliptin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vildagliptin suppliers with NDC on PharmaCompass.
Vildagliptin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vildagliptin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Vildagliptin GMP manufacturer or Vildagliptin GMP API supplier for your needs.
A Vildagliptin CoA (Certificate of Analysis) is a formal document that attests to Vildagliptin's compliance with Vildagliptin specifications and serves as a tool for batch-level quality control.
Vildagliptin CoA mostly includes findings from lab analyses of a specific batch. For each Vildagliptin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vildagliptin may be tested according to a variety of international standards, such as European Pharmacopoeia (Vildagliptin EP), Vildagliptin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vildagliptin USP).